relative stereochemistry shown. RCM of each of these
diallylated compound (9a and 9b) gave 10a and 10b,
respectively,12 each as a single diastereoisomer as shown;
the indicated stereochemistry is based upon the results of
the previous sequence (see Scheme 1) and literature prece-
dence.9,10
Synthesis of the alternative cis isomer 12 was achieved
by reversing the order of the alkylation steps, i.e., alkylation
of 1 with allyl bromide followed by alkylation with methyl
iodide. This resulted in 11, an epimer of 9a, that gave rise
to 12 upon RCM (see Scheme 2). Therefore, it is possible
to prepare either the cis or trans R-substituted cyclic â-amino
acids using this methodology. It is interesting to note that
while cis isomers of type 12 have not been used to prepare
â-peptides, they are of interest as inhibitors of matrix
metalloproteases.14
Compound 16a was next converted into (+)-1 (such that the
sequence outlined in Scheme 1 could be repeated with
optically active material) by ester hydrolysis and re-esteri-
fication with diazomethane. This material gave an optical
rotation18 in close agreement with literature.20 We also
prepared the methyl ester (+)-1 from 13 by alkylation with
methyl bromoacetate, rather than tert-butyl bromoacetate, to
give 14b. Hydrolysis of the chiral auxiliary gave (-)-15b,
which was then subjected to the Curtius rearrangement
conditions to give (+)-1 directly (Scheme 3).
Scheme 3a
In the final sequence, we demonstrate that it is possible
to prepare a single enantiomer of the cyclic â-amino acids
using Evans chiral auxiliary chemistry15,16 to prepare (+)-1,
which was then subjected to our R-allylation, RCM strategy.
The anion of the N-acyl oxazolidinone 1317 was alkylated
with tert-butyl bromoacetate to give the alkylated imide 14a18
in 83%. The absolute configuration of 14a was confirmed
as shown by X-ray crystallography.19 Cleavage of the chiral
auxiliary was then carried out using lithium hydroperoxide15
to give the differentially protected diacid 15a18 in 95%. A
Curtius rearrangement procedure was then adopted for the
conversion of 15a to give the optically active18 Cbz-protected
â-allyl glycine tert butyl ester 16a. This was achieved by
refluxing the acid 15a in the presence of diphenylphosphoryl
azide and triethylamine15 to give an intermediate isocyanate,
which was subsequently trapped with benzyl alcohol. This
procedure was also carried out using tert-butyl alcohol as
the trapping agent to give the known Boc-protected derivative
17, the optical rotation18 of which agreed with literature.16
(14) Duan, J.; Ott, G.; Chen, L.; Lu, Z.; Maduskuie, T. P., Jr.; Voss, M.
E.; Xue, C.-B. PCT Int. Appl. WO 0170673 A2 20010927, 2001.
(15) Evans, D. A.; Wu, L. D.; Wiener, J. J.; Johnson, J. S.; Ripin, D. H.
B.; Tedrow J. S. J. Org. Chem. 1999, 64, 6411.
(16) Sibi, M. P.; Deshpande, P. K. J. Chem. Soc., Perkin Trans. 1 2000,
1461.
(17) Evans, D. A.; Britton, T. C.; Dorow, R. L.; Dellaria, J. F., Jr.
Tetrahedron 1998, 44, 5525.
(18) Optical rotations [R]D for: (+)-1, +4.2° (c 2, CHCl3) (lit.20 +4.7°
(c 2, CHCl3)); (+)-2, +8.2° (c 1, DCM); (-)-3, -31.2° (c 1.0 CHCl3)
(lit.21 -33.5°); (-)-4, -18.4° (c 0.9, CHCl3) (lit.13 -18° (c 0.9, CHCl3));
(+)-14a, +51.2° (c 1, DCM); (+)-15a, +3.4° (c 1.4 DCM) (lit.16 +3.4° (c
1.4, DCM)); (-)-15b, -2.4° (c 0.5, DCM); (+) 16a, +1.8° (c 1, DCM);
(-)-17, -9.8° (1.1 MeOH) (lit.16 -10.09° (c 1.1 MeOH)).
(19) Crystallographic data for 14a: C21H27NO5, M ) 373.44, crystal
dimensions 0.55 × 0.38 × 0.33 mm3, orthorhombic, a ) 5.773 (6) Å, b )
10.373 (13) Å, c ) 33.36 (4) Å, R ) 90 (2)°, â ) 90 (2)°, γ ) 90 (2)°, V
a Conditions: (i) NaHMDS, tert-butylbromoacetate or methyl
bromoacetate, THF, -78 °C; (ii) LiOH-H2O2, THF-H2O, 0 °C;
(iii) DPPA, Et3N, toluene reflux, BnOH; (iv) TFA/CH2Cl2, Me2S,
CH2N2; (v) LiCl, 2 equiv LDA, allyl bromide, THF, from -78 °C
to room temperature; (vi) 7, CH2Cl2; (vii) H2, Pd/C, MeOH then
DIEA, CbzCl, DMAP, CH2Cl2; DPPA, Et3N, toluene reflux,
t-BuOH.
) 1998 (4) Å3, space group P2(1)2(1)2(1), Z ) 4, F(000) ) 800, Dcalcd
)
1.242 mg/m3, absorption coefficient 0.088 mm-1, θ range for data collection
) 2.31-26.41, index ranges -5 e h e 2, -12 e k e 12, -41 e l e 41,
data/restraints/parameters ) 3563/0/244, GOF on F2 was 0.905, final R
indices [I > 2σ(I)] R1 ) 0.0322, wR2 ) 0.0656, R indices (all data) R1 )
0.0454, wR2 ) 0.0685, largest difference peak and hole were 0.125 and
-0.185 eÅ-3, respectively. A unique data set was measured at 168(2) K.
Of the 8924 reflections obtained, 3563 were unique (Rint ) 0.0221) and
used in the full-matrix least-squares refinement. The structure was solved
by direct methods. Hydrogen atoms were fixed in idealized positions. All
non-hydrogen atoms were refined with anisotropic atomic displacement
parameters. Neutral scattering factors and anomalous dispersion corrections
for non-hydrogen atoms were taken from Ibers and Hamilton (Ibers, J. A.,
Hamilton, W. C., Eds.; International Tables for Crystallography; Kynoch
Press: Birmingham, UK, 1992; Vol. C).
The final stage of the synthesis of the optically active
cyclic â-amino acid (Scheme 3) was carried out as described
for the racemic series (see Scheme 1). In particular, (+)-1
(20) For an alternative synthesis, see: Shono, T.; Kise, N.; Sanda, F.;
Ohi, S.; Tsubata, K. Tetrahedron Lett. 1988, 29, 231.
Org. Lett., Vol. 4, No. 21, 2002
3665